Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03522298 |
|---|---|
| Brief Title: | Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma |
| First Submitted : | March 20, 2018 |
| First Submitted that Met QC Criteria : | May 9, 2018 |
| First Posted : | May 11, 2018 |
| Last Update Submitted that Met QC Criteria : | March 13, 2024 |
| Last Update Posted : | March 15, 2024 |